Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Cognitive impairment in schizophrenia.

Keefe RS, Harvey PD.

Handb Exp Pharmacol. 2012;(213):11-37. doi: 10.1007/978-3-642-25758-2_2. Review.

PMID:
23027411
2.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
3.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
4.

Treatment of cognitive dysfunction in schizophrenia.

Peuskens J, Demily C, Thibaut F.

Clin Ther. 2005;27 Suppl A:S25-37. Review.

PMID:
16198199
5.

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Keefe RS, Silva SG, Perkins DO, Lieberman JA.

Schizophr Bull. 1999;25(2):201-22.

PMID:
10416727
6.

The effects of clozapine on cognitive functioning in schizophrenia.

McGurk SR.

J Clin Psychiatry. 1999;60 Suppl 12:24-9. Review.

7.

[Learning potential and cognitive remediation in schizophrenia].

Raffard S, Gely-Nargeot MC, Capdevielle D, Bayard S, Boulenger JP.

Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Review. French.

PMID:
19748372
8.

The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.

Andersen R, Fagerlund B, Rasmussen H, Ebdrup BH, Aggernaes B, Gade A, Oranje B, Glenthoj B.

Eur Psychiatry. 2013 Aug;28(6):332-9. doi: 10.1016/j.eurpsy.2012.06.003. Epub 2012 Sep 19.

PMID:
22999439
9.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
10.
11.

Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.

Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P.

Psychiatry Res. 2008 Sep 30;160(3):316-26. doi: 10.1016/j.psychres.2007.07.011. Epub 2008 Jun 24.

PMID:
18579217
12.

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.

Sharma T, Antonova L.

Psychiatr Clin North Am. 2003 Mar;26(1):25-40. Review.

PMID:
12683258
13.

Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.

Radek RJ, Kohlhaas KL, Rueter LE, Mohler EG.

Curr Pharm Des. 2010 Jan;16(3):309-22. Review.

PMID:
20109141
14.

[Schizophrenia, psychotropic drugs and cognition].

Fakra E, Kaladjian A, Adida M, Cermolacce M, Belzeaux R, Azorin JM.

Encephale. 2011 Dec;37 Suppl 2:S137-42. doi: 10.1016/S0013-7006(11)70041-0. Review. French.

PMID:
22212844
15.

Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.

Chung YC, Lee CR, Park TW, Yang KH, Kim KW.

World J Biol Psychiatry. 2009;10(2):156-62.

PMID:
19514097
16.

[MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].

Jedrasik-Styła M, Ciołkiewicz A, Denisiuk M, Linke M, Parnowska D, Gruszka A, Jarema M, Wichniak A.

Psychiatr Pol. 2012 Mar-Apr;46(2):261-71. Polish.

PMID:
23214396
17.

Treating impaired cognition in schizophrenia.

Ibrahim HM, Tamminga CA.

Curr Pharm Biotechnol. 2012 Jun;13(8):1587-94. Review.

PMID:
22283754
18.

Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Green MF.

J Clin Psychiatry. 2006;67 Suppl 9:3-8; discussion 36-42. Review.

19.

Cognitive effects and antipsychotic treatment.

Kasper S, Resinger E.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:27-38. Review.

PMID:
12504070
20.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265

Supplemental Content

Support Center